Clinical Trial Update: A Study of the Safety, Imaging and Clinical Outcomes of THR-18 in Acute Stroke Subjects Treated With tPA [Phase 2]

View source ↗

Summary

Phase 2 study evaluating THR-18 for safety, imaging and clinical outcomes in ischemic stroke patients treated with tPA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• THR-18

Snippet

Sponsor: D-Pharm Ltd. | Conditions: Ischemic Stroke | Phase 2 | Status: UNKNOWN